Apotex Accused Of Infringing Novo Nordisk Diabetes Drug
The largest producer of generic drugs in Canada is infringing U.S. patents for Rybelsus, a medication for people with Type 2 diabetes that also is used for weight loss, drugmaker Novo...To view the full article, register now.
Already a subscriber? Click here to view full article